ArticleJAMA network open2026

Pembrolizumab vs Nivolumab as Initial Treatment for Advanced, Unresectable, or Metastatic Melanoma.

Garth W Strohbehn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.